These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 33437907)

  • 21. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
    Hwang IC; Chang J; Kim K; Park SM
    Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis.
    Abdelmalak J; Tan N; Con D; Eslick G; Majeed A; Kemp W; Roberts SK
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Yang LS; Yan LJ; Meng GX; Ding ZN; Yao SY; Li HC; Dong ZR; Chen ZQ; Hong JG; Li T
    Nutr Cancer; 2023; 75(2):461-469. PubMed ID: 36411493
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
    Liu Y; Ren T; Xu X; Jin J
    Eur J Cancer Prev; 2022 Jan; 31(1):35-43. PubMed ID: 33470689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
    Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
    J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
    Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis.
    Liu M; Zhao T; Zhang Y; Zhang AM; Geng J; Xia X
    Front Cell Infect Microbiol; 2023; 13():1226755. PubMed ID: 37771696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
    Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
    Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Yu Y; Liu L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.
    Yang Y; Zhang D; Feng N; Chen G; Liu J; Chen G; Zhu Y
    Gastroenterology; 2014 Nov; 147(5):1031-42. PubMed ID: 25127680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis.
    Yan LJ; Yao SY; Li HC; Meng GX; Liu KX; Ding ZN; Hong JG; Chen ZQ; Dong ZR; Li T
    J Clin Transl Hepatol; 2022 Oct; 10(5):835-846. PubMed ID: 36304506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
    Wang J; Li X
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis.
    Shin S; Lee SH; Lee M; Kim JH; Lee W; Lee HW; Park MS; Park S; Kim TS; Choi DH
    Medicine (Baltimore); 2020 Feb; 99(9):e19008. PubMed ID: 32118712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies.
    Bravi F; Tavani A; Bosetti C; Boffetta P; La Vecchia C
    Eur J Cancer Prev; 2017 Sep; 26(5):368-377. PubMed ID: 27111112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.